The CMF Bone Growth Stimulator's state-of-the-art, FDA approved Combined Magnetic Field (CMF) technology provides medical professionals with an effective tool for healing problem fractures and spinal fusion procedures. Outstanding results and excellent patient compliance are reasons why our company is a leader in the industry. Data supporting a once daily 30 minute treatment with heal rates up to 89% and 49% increase in spinal fusion success.
The 30 Minute Solution— A noninvasive bone growth stimulator indicated as an adjunct electromagnetic treatment for non-union fractures (OL1000) and spinal fusion (Spinalogic).Unique Signal Technology
State-of-the-art Combined Magnetic Field (CMF) technology, which increases both the specificity and potency of treatment.
CMF signal does not diminish as it passes through skin, muscle, and fat
30 minute treatment time
Easy To Use
No direct skin contact
Can be placed over any cast
Can be used with internal or external fixation devices
All-in-one device with no messy gels to apply or clean up
Simple one button operation and easy to understand graphic icons.
CMF OL1000 Bone Growth Stimulators are portable, battery-powered medical devices indicated for use in the noninvasive treatment of an established nonunion fracture acquired secondary to trauma, excluding all vertebrae and flat bones.
The device has the following features:
Lightweight and comfortable
Easy-to-use & Noninvasive
Requires simple, one-button operation
Device is worn for only 30 minutes per day
Can be used with internal or external fixation or over a cast
This treatment has been shown in pre-clinical studies to help the body's own healing process begin working. Clinical studies have shown an increased chance of healing of 60.7% in patients with nonunions that averaged 29.3 months from injury. Registry data on over 2300 patients reports a heal rate of 75.1%.
New Research Proves 100% Therapeutic Coverage for Interbody and Posterolateral Fusion Sites.
Click to watch video.
Read Full Study:
Combined magnetic fields provide robust coverage for interbody and posterolateral lumbar spinal fusion sites